# The Efficacy and Safety of a Compound Glutamine Capsule in the Prevention of Chemotherapy-induced Mucositis

> **NCT04988971** · PHASE3 · UNKNOWN · sponsor: **Meng Qiu** · enrollment: 90 (estimated)

## Conditions studied

- Mucositis
- Chemotherapeutic Toxicity

## Interventions

- **DRUG:** a compound glutamine capsule
- **DRUG:** a compound glutamine capsule simulated placebo

## Key facts

- **NCT ID:** NCT04988971
- **Lead sponsor:** Meng Qiu
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-30
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04988971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04988971, "The Efficacy and Safety of a Compound Glutamine Capsule in the Prevention of Chemotherapy-induced Mucositis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04988971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*